Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment

Q Gao, J Feng, W Liu, C Wen, Y Wu, Q Liao… - Advanced drug delivery …, 2022 - Elsevier
The therapeutic limitations such as insufficient efficacy, drug resistance, metastasis, and
undesirable side effects are frequently caused by the long duration monotherapy based on …

Phytosomes as innovative delivery systems for phytochemicals: A comprehensive review of literature

M Barani, E Sangiovanni, M Angarano… - International Journal …, 2021 - Taylor & Francis
Nowadays, medicinal herbs and their phytochemicals have emerged as a great therapeutic
option for many disorders. However, poor bioavailability and selectivity might limit their …

Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies

H Mirzaei, A Shakeri, B Rashidi, A Jalili… - Biomedicine & …, 2017 - Elsevier
Curcumin, a hydrophobic polyphenol, is the principal constituent extracted from dried
rhizomes of Curcuma longa L.(turmeric). Curcumin is known as a strong anti-oxidant and …

Curcumin and colorectal cancer: An update and current perspective on this natural medicine

W Weng, A Goel - Seminars in cancer biology, 2022 - Elsevier
Colorectal cancer (CRC) is one of most common malignancies worldwide and its incidence
is still growing. In spite of recent advances in targeted therapies, their clinical efficacy has …

NF-κB pathways in the development and progression of colorectal cancer

M Patel, PG Horgan, DC McMillan, J Edwards - Translational Research, 2018 - Elsevier
Nuclear factor-κB (NF-κB) has been widely implicated in the development and progression
of cancer. In colorectal cancer (CRC), NF-κB has a key role in cancer-related processes …

[HTML][HTML] Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase IIa trial

LM Howells, COO Iwuji, GRB Irving, S Barber… - The Journal of …, 2019 - Elsevier
Background Curcumin is the main active ingredient of the spice turmeric, investigated
extensively for putative anticancer properties. Objectives This phase IIa open-labelled …

Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression

K Yoshida, S Toden, P Ravindranathan, H Han… - …, 2017 - academic.oup.com
Abstract Development of resistance to chemotherapeutic drugs is a major challenge in the
care of patients with pancreatic ductal adenocarcinoma (PDAC). Acquired resistance to …

The Notch signaling pathway as a mediator of tumor survival

KM Capaccione, SR Pine - Carcinogenesis, 2013 - academic.oup.com
The Notch signaling pathway is evolutionarily conserved and responsible for cell fate
determination in the developing embryo and mature tissue. At the molecular level, ligand …

Phytosomal curcumin inhibits tumor growth in colitis‐associated colorectal cancer

RM Marjaneh, F Rahmani… - Journal of cellular …, 2018 - Wiley Online Library
Colorectal‐cancer (CRC) is the third leading cause of death due to cancer, supporting the
need for identification of novel anticancer drug to improve the efficacy of current‐therapy …

[HTML][HTML] The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer

W Sun, J Li, L Zhou, J Han, R Liu, H Zhang, T Ning… - Theranostics, 2020 - ncbi.nlm.nih.gov
Oxaliplatin (OXA) resistance is the major obstacle to the anticancer effects of chemotherapy
in colorectal cancer (CRC) patients. MicroRNAs (miRNAs) play an important role in the …